Cardiovascular Devices Global Market Report 2018

1
Cardiovascular Devices Global Market Report 2018
Including Cardiovascular Surgery Devices
Cardiac Rhythm Management (CRM) Devices
Interventional Cardiology Devices Defibrillator
Devices Peripheral Vascular Devices Prosthetic
Heart Valve Device Electrophysiology Devices
Cardiac Assist Devices Covering Medtronic plc,
Abbott Laboratories, Boston Scientific
Corporation, Cardinal Health Inc., Edwards
Lifesciences
Feb 2018
2
Reasons to Purchase

• Outperform competitors using accurate up to date
  demand-side dynamics information.
• Identify growth segments for investment.
• Facilitate decision making on the basis of
  historic and forecast data and the drivers and
  restraints on the market.
• Create regional and country strategies on the
  basis of local data and analysis.
• Stay abreast of the latest customer and market
  research findings
• Benchmark performance against key competitors.
• Develop strategies based on likely future
  developments.
• Utilize the relationships between key data sets
  for superior strategizing.
• Suitable for supporting your internal and
  external presentations with reliable high
  quality data and analysis
• Gain a global perspective on the development of
  the market.
• Report will be updated with the latest data and
  delivered to you within 3-5 working days of
  order.
• Scope
• Markets Covered Cardiovascular Surgery Devices
  Cardiac Rhythm Management (CRM) Devices
  Interventional Cardiology Devices Defibrillator
  Devices Peripheral Vascular Devices Prosthetic
  Heart Valve Device Electrophysiology Devices
  Cardiac Assist Devices
• Companies Mentioned Medtronic plc, Abbott
  Laboratories, Boston Scientific Corporation,
  Cardinal Health Inc., Edwards Lifesciences
• Countries Brazil, China, France, Germany, India,
  Italy, Japan, Spain, Russia, UK, USA and
  Australia.
• Regions Asia-Pacific, Western Europe, Eastern
  Europe, North America, South America,
• Middle East And Africa

3
Cardiovascular Devices Market Characteristics
Cardiovascular devices are designed to diagnose,
prevent, monitor and treat diseases related to
the cardiovascular system Including heart
diseases and related health problems. They
include arrhythmia detectors, noninvasive blood
pressure measurement systems, diagnostic
intravascular catheters, external cardiac
compressors, coronary vascular physiologic
simulation software devices, external
programmable pacemaker pulse generators, cardiac
monitors, cardiopulmonary bypass defoamers,
echocardiographs, vascular graft prostheses,
electrocardiographs, defibrillators and
others. The cardiovascular devices market in
this report is segmented into cardiovascular
surgery devices, cardiac rhythm management (CRM)
devices, interventional cardiology devices,
defibrillator devices, peripheral vascular
devices, prosthetic heart valve device,
electrophysiology devices and cardiac assist
devices Cardiovascular Surgery
Devices Cardiovascular surgery devices are used
in Cardiac Rhythm Management (CRM) Devices These
devices are used to manage the heart rate
or Interventional Cardiology Devices Intervention
al cardiology devices are used in Defibrillator
Devices Defibrillator Devices are used in
the Peripheral Vascular Devices Peripheral
vascular devices are used to
4
Prosthetic Heart Valve Devices Electrophysiology
Devices are used in the diagnosis and treatment
of Cardiac Assist Devices are artificial
mechanic pumps that assist the heart in In this
report market value is defined as the revenues
organizations earn by selling their goods and
services within the specified market, based on
the price at which they sell. Only goods and
services traded between entities are
included. The revenues for a specified geography
are consumption values that is, they are
revenues generated by organizations in the
specified geography within the specified
market, irrespective of where they are produced.
5
Cardiovascular Devices Market Historic Growth
The global cardiovascular devices market grew
from X billion in 2013 to X billion in 2017 at
a compound annual growth rate (CAGR) of X. The
chart and table below shows the year-on-year
growth of the global cardiovascular devices
market during 2013 2017.
Drivers of the Market Restraints on the Market
6
Cardiovascular Devices Market Forecast Growth
The global cardiovascular devices market is
expected to grow from XX billion in 2017 to
61.4 billion in 2021 at a compound annual growth
rate (CAGR) of XX. The chart and table below
shows the year-on-year growth of the global
cardiovascular devices market during 2017 - 2021.
Drivers of the Market Restraints on the Market
7
Cardiovascular Devices Market Segmentation
The chart and table below shows the split of the
cardiovascular devices market in 2017.
8
The total market value for cardiovascular devices
was X billion in 2017. The markets that are
covered include Cardiovascular Surgery Devices
Cardiac Rhythm Management (CRM) Devices
Interventional Cardiology Devices Defibrillator
Devices Peripheral Vascular Devices Prosthetic
Heart Valve Device Electrophysiology Devices
Cardiac Assist Devices. Cardiovascular Surgery
Devices was the X largest segment in the
cardiovascular devices market with X share of
the market. The market value for the
cardiovascular surgery devices was X billion in
2017. Cardiac Rhythm Management (CRM) Devices
made up around X share of the market. The
market value for the cardiac rhythm management
(CRM) Devices was X billion in 2017.
9
Cardiovascular Devices Market Regional And
Country Analysis
The Asia Pacific was the largest region in the
cardiovascular devices market in 2017,
cardiovascular devices for X billion or X
market share. North America was the x largest
region cardiovascular devices for X billion or
X market share. Western Europe was the x
largest region cardiovascular devices for X
billion or X market share.
10
Cardiovascular Devices Market Competitive
Landscape
The leading competitors in the global
cardiovascular devices market are Medtronic plc,
Abbott Laboratories, Boston Scientific
Corporation, Cardinal Health Inc., Edwards
Lifesciences. The chart and table below displays
the percentage market share of the top players
in the cardiovascular devices market industry.
Medtronic plc generated revenues of XX billion
for the financial year 2016, an XX increase
from the previous year. Abbott Laboratories
generated revenues of XX billion for the
financial year 2016, an XX decrease from the
previous year. Boston Scientific Corporation
generated revenues of XX billion for the
financial year 2016, an XX increase from the
previous year. Cardinal Health, Inc. generated
revenues of XX billion for the financial year
2016, an XX increase from the previous year.
11

• Edwards Lifesciences generated revenues of XX
  billion for the financial year 2016, an XX
  increase from the previous year.
• Terumo Corporation generated revenues of XX
  billion for the financial year 2016, an XX
  increase from the previous year.
• Braun Holding GmbH Co. KG generated revenues of
  XX billion for the financial year 2016, an XX
  increase from the previous year.
• Johnson Johnson Inc. generated revenues of XX
  billion for the financial year 2016, an XX
  decrease from the previous year.
• R. Bard, Inc. (U.S.) generated revenues of XX
  billion for the financial year 2016, an XX
  increase from the previous year.
• Company Profile Medtronic plc
• Overview
• Medtronic was the largest company in the
  cardiovascular devices market in 2017, with an
  XX share of the market. It is a medical
  technology, services and solutions company and
  serves hospitals, physicians, clinicians and
  patients in approximately 160 countries
  worldwide. Medtronic was founded in 1949 and is
  headquartered in Dublin, Ireland.
• Products and Services
• The company operates through the following
  divisions-
• The Cardiac and Vascular group caters to
• The Minimally Invasive Technologies Group
  provides
• The Restorative Therapies group provides
• The Diabetes Group consists of

12
Strategy Medtronics growth strategy is to
capture untapped business opportunities in
emerging markets through acquisitions. For
instance, In January 2015, Medtronic acquired
Covidien Plc for 49.9 Billion in cash. This deal
gives Medtronic the Covidiens portfolio of
cardiac and vascular devices, Financial
Performance Medtronics cardiac and vascular group
division involved in the cardiovascular devices
manufacturing, generated revenues of XX
billion for the financial year 2017, a XX
increase from the previous year. The company had
a market Abbott Laboratories Overview Products
and Services Strategy Financial
Performance Boston Scientific Corporation Overvie
w Products and Services Strategy Financial
Performance Cardinal Health Inc. Overview Product
s and Services Strategy Financial
Performance Edwards Lifesciences Overview Product
s and Services Strategy Financial Performance